Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 37,393 | 17,505 | 23,854 | N/A |
| Marketable Securities | 37,435 | N/A | N/A | N/A |
| Receivables | 329 | 269 | 45 | N/A |
| Inventories | 133 | 0 | N/A | N/A |
| TOTAL | $76,183 | $18,014 | $24,262 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,782 | 904 | 785 | N/A |
| Other Non-Current Assets | 228 | 228 | 238 | 0 |
| TOTAL | $2,010 | $1,132 | $1,023 | $N/A |
| Total Assets | $78,193 | $19,146 | $25,285 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,316 | 545 | 583 | 0 |
| Accrued Expenses | 3,016 | 741 | 1,086 | N/A |
| TOTAL | $5,874 | $3,342 | $3,475 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 13,511 | 651 | 2,259 | N/A |
| Deferred Revenues | 188 | 250 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 74,598 | 66,091 | 0 |
| TOTAL | $13,623 | $75,276 | $68,421 | $N/A |
| Total Liabilities | $19,497 | $78,618 | $71,896 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 21,416 | N/A | N/A | N/A |
| Common Shares | 2 | N/A | N/A | N/A |
| Retained earnings | -89,428 | -60,780 | -47,463 | N/A |
| TOTAL | $58,696 | $-59,472 | $-46,611 | $N/A |
| Total Liabilities And Equity | $78,193 | $19,146 | $25,285 | $0 |